Literature DB >> 8029805

The development of hirudin as an antithrombotic drug.

F Markwardt1.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8029805     DOI： 10.1016/0049-3848(94)90032-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  40 in total

Review 1.  Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.

Authors:  N Lubenow; A Greinacher
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

2.  Trousseau's syndrome treated with long-term subcutaneous lepirudin (case report and review of the literature).

Authors:  A C Andreescu; M Cushman; J M Hammond; M E Wood
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

3.  Surface characterization and platelet adhesion studies on polyethylene surface with hirudin immobilization.

Authors:  J C Lin; S M Tseng
Journal:  J Mater Sci Mater Med       Date:  2001-09       Impact factor: 3.896

Review 4.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

5.  Construction, expression and refolding of a bifunctional fusion protein consisting of C-terminal 12-residue of hirudin-PA and reteplase.

Authors:  Ling Gao; Chun Zhang; Lingling Li; Lan Liang; Xuan Deng; Wutong Wu; Zhiguo Su; Rong Yu
Journal:  Protein J       Date:  2012-04       Impact factor: 2.371

6.  A novel targeted multi-functional fusion protein possesses inhibitory activities against bacteria, thrombin and platelet aggregation.

Authors:  Jiange Gao; Zongli Hu; Zhiping Zhao; Guanglei Liu; Yanrong Ren; Guoping Chen
Journal:  Protein J       Date:  2011-12       Impact factor: 2.371

7.  Computational design, functional analysis and antigenic epitope estimation of a novel hybrid of 12 peptides of hirudin and reteplase.

Authors:  Yingting Cai; Jingxiao Bao; Xingzhen Lao; Heng Zheng; Jianhua Chen; Rong Yu
Journal:  J Mol Model       Date:  2015-08-13       Impact factor: 1.810

Review 8.  Hirudin and excess bleeding. Implications for future use.

Authors:  U Zeymer; K L Neuhaus
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

9.  Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.

Authors:  G De Simone; A Lombardi; S Galdiero; F Nastri; R Della Morte; N Staiano; C Pedone; M Bolognesi; V Pavone
Journal:  Protein Sci       Date:  1998-02       Impact factor: 6.725

Review 10.  Developments in antithrombotic therapy: state of the art anno 1996.

Authors:  H ten Cate; M T Nurmohamed; J W ten Cate
Journal:  Pharm World Sci       Date:  1996-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.